These Analysts Increase Their Forecasts On HCA Healthcare After Q4 Results - HCA Healthcare (NYSE:HCA)

Core Viewpoint - HCA Healthcare Inc. reported mixed financial results for the fourth quarter of 2025, with revenues slightly below expectations but adjusted earnings exceeding forecasts [1][2]. Financial Performance - Total revenues for HCA in Q4 2025 were $19.513 billion, a 6.7% increase year-over-year, but below the consensus estimate of $19.67 billion [1]. - Adjusted earnings per share were $8.01, up from $6.22 a year ago, surpassing the consensus estimate of $7.43 [1]. Future Outlook - HCA Healthcare forecasts fiscal 2026 earnings per share in the range of $29.10 to $31.50, compared to the consensus of $29.54 [2]. - The company anticipates 2026 sales between $76.5 billion and $80 billion, while the consensus estimate stands at $79.08 billion [2]. Stock Performance - HCA Healthcare shares closed at $505.84 following the earnings announcement [3]. - Analysts have adjusted their price targets for HCA Healthcare in response to the earnings results [3].